[Disclaimer: This article is for educational purposes only. Always consult with a qualified healthcare provider before starting any peptide protocol.]
A guy sent me his labs last month feeling good about them.
Normal creatinine and eGFR readings, which means everything is kosher according to his primary care physician.
Here’s what the doctor didn’t tell him:
Creatinine and estimated glomerular filtration rate (eGFR), the two markers conventional labs lean on to assess kidney health, don’t flag meaningful dysfunction until you’ve already lost 40 to 60 percent of your existing kidney function.
So how do we fix this?
I AM confident the best approach involves understanding the relationship between Klotho and kidney function.
Klotho is a longevity-associated protein produced primarily in the kidneys that governs aging, mineral metabolism, cardiovascular health, cognitive function, and inflammation across nearly every tissue system in your body.
The research world has been building a compelling case around this molecule, yet in the anti-aging space it still remains relatively unknown.
If you’re serious about optimizing your kidney health, and don’t want to find yourself in the same predicament as the guy I just talked about, you must understand what Klotho does and why its production is steadily declining.
And those two things are exactly what this article is going to be about.
Quick Takeaways
- Klotho is produced primarily in the kidneys and declines with age. Other contributing factors to its lowered production include kidney disease and inflammation (i.e. poor metabolic health).
- Cystatin C is a more sensitive kidney function marker than creatinine and belongs on any standard optimization panel.
- Fibroblast growth factor 23 (FGF23) rises as Klotho falls, and that combination predicts negative outcomes associated with accelerated aging such as cardiovascular events and bone loss.
- Chronic kidney disease is a Klotho deficiency state, and protecting kidney function helps preserve your overall health.
- An engineered third-party-verified Klotho protein already exists, and I helped bring it to the market so more people can tap into the longevity benefits of Klotho.
Why Mainstream Medicine Is Approaching Kidney Health The Wrong Way
The conventional model of kidney health is built around damage control and reactivity, rather than optimization and prevention.
Your doctor orders a basic metabolic panel, checks creatinine, maybe calculates an eGFR, and tells you everything looks fine.
What they’re NOT doing is measuring the earliest molecular signals of kidney aging… the ones that predict hidden signs of dysfunction years or decades before your creatinine ever moves.
This is the fundamental failure of sick-care medicine: Waiting for organ damage to become undeniable before intervening, at which point you’ve already lost significant biological ground.
But if you know what you’re doing, Klotho changes this equation entirely.
What Is Klotho, and Why Does It Matter?
Klotho is a transmembrane protein first identified by accident in 1997 by Makoto Kuro-o’s research team, who were investigating a hypertension gene when an insertion disrupted something else entirely.
They named it after the Greek Fate who spins the thread of life, and the name turned out to be prophetic.
Mice lacking the Klotho gene aged rapidly:
- Arteries calcified
- Bones demineralized
- Skin thinned out
- Lungs broke down
- Gonads atrophied
All of the test animals were dead within eight to nine weeks in that original 1997 Nature study.
But mice engineered to overexpress Klotho ran the opposite direction, living roughly 20 to 30 percent longer than their littermates.
That single accidental discovery suggested something radical: A meaningful piece of what we casually call aging is a signaling problem with an actual molecular address.
Klotho exists in two primary forms…
- Membrane-bound Klotho (mKlotho), which acts as a co-receptor for FGF23 in the kidney.
- Soluble Klotho (sKlotho), which is cleaved from the membrane and circulates systemically
The latter functions as a hormone that influences distant tissues including the brain, heart, muscle, and vasculature.
The kidney’s distal tubules are the dominant source of both forms, with smaller amounts produced in the brain’s choroid plexus, the parathyroid glands, and reproductive tissue.
When kidney function declines, systemic Klotho availability collapses and the downstream consequences ripple through your entire physiology.
The FGF23-Klotho Axis: Why This Signaling Pathway Defines Your Aging Trajectory
FGF23 is a hormone produced by bone cells (osteocytes) in response to elevated phosphate and vitamin D.
Its primary job is to tell the kidney to excrete phosphate and suppress 1,25-dihydroxyvitamin D (active vitamin D) production.
But FGF23 cannot do this without Klotho.
Membrane-bound Klotho in the kidney acts as the obligate co-receptor for FGF23, essentially chaperoning the signal into the cell.
When Klotho declines, FGF23 signaling in the kidney breaks down.
The body compensates by producing more FGF23 — sometimes dramatically more — in an attempt to maintain phosphate homeostasis through sheer volume.
But there’s a catch: Chronically elevated FGF23 is independently associated with left ventricular hypertrophy and higher cardiovascular mortality risk in populations with kidney disease.
It’s also linked to the following undesirable outcomes:
- Suppressed immune function
- Accelerated vascular calcification
- Worsening kidney inflammation and fibrosis
- Blunted vitamin D activation
As you can clearly see, an FGF23-Klotho imbalance is the upstream driver of most age-associated (and oftentimes lifestyle-driven) disease.
Cystatin C: The Kidney Marker You Should Already Be Tracking
Let’s talk about Cystatin C, a marker worth measuring if your current focus centers around healing and restoring your kidney function.
Cystatin C is a small protein produced at a constant rate by every nucleated cell in your body and filtered out almost exclusively by the kidneys.
Unlike creatinine, it isn’t influenced by factors such as muscle mass, diet, hydration, or race.
Therefore, it gives a far more accurate picture of true filtration capacity.
Especially in people with lower muscle mass, women, older adults, and anyone who doesn’t fit the average body composition model used to estimate GFR from creatinine.
A landmark NEJM study demonstrated Cystatin C-based eGFR predicted kidney disease progression and mortality more accurately than creatinine-based eGFR across diverse populations.
In other words, two people with identical creatinine-based eGFR scores can have vastly different true filtration rates.
If your doctor isn’t ordering Cystatin C, ask for it.
I would rank it as one of the best lab tests available for biological aging, and not just something reserved for people with established kidney disease.
Klotho and Chronic Kidney Disease: A Deficiency State
Chronic kidney disease (CKD) is, at its molecular core, a state of Klotho deficiency.
As kidney function declines across the CKD staging spectrum, Klotho expression in the kidney tubules falls precipitously, often declining before eGFR itself moves into diagnostic range.
This is why Klotho is being studied as an early biomarker of CKD progression, and one that may outperform standard markers in detecting decline before irreversible damage sets in.
Research in nondiabetic CKD populations found lower serum Klotho independently predicted a higher CKD mortality risk.
And the discovery lab from which Klotho originated has since published research in Kidney International on recombinant alpha-Klotho as a potential therapy to slow CKD progression and protect the heart in kidney disease.
The step-by-step progression is straightforward:
- Loss of Klotho impairs FGF23 signaling, driving FGF23 elevation
- Elevated FGF23 directly promotes kidney fibrosis and inflammation
- Kidney fibrosis further destroys Klotho-producing tubular cells
- The cycle consisting of steps #1-3 accelerates, compounding damage at every stage
This is a vicious feedback loop that conventional medicine has no meaningful pharmacological answer to as of right now… at least not one that’s reached your local nephrologist’s office.
Which is exactly why prevention and early optimization matter so much more than rescue therapy.
What Drives Klotho Decline (Beyond Age)
Age is the most well-established driver of Klotho reduction, but it is far and away from the only one.
The following factors are independently associated with lower Klotho levels:
- Chronic inflammation and elevated IL-6 and TNF-alpha
- Insulin resistance and metabolic syndrome
- Hyperphosphatemia from processed food and drink
- Vitamin D deficiency
- Oxidative stress
- Hypertension
- Obesity
- Low physical activity
- Sleep disruption
Every single one of those factors is addressable, including the fasting insulin test your doctor probably isn’t running.
Fortunately, you can address the upstream drivers of Klotho decline systematically before the lab results ever move into “abnormal” ranges.
Strategies to Support Klotho and Kidney Health
I want to be clear: I AM NOT prescribing you a medical treatment.
All I’m doing is laying out what the mechanistic and clinical evidence consistently points toward for people who want to protect their kidneys proactively.
And based on all the information presented so far, the roadmap should be fairly obvious:
- Restrict dietary phosphate from ultra-processed foods and phosphate-additive-laden products
- Optimize vitamin D status, targeting 25-OH Vitamin D between 60 and 80 ng/mL
- Engage in consistent resistance training, which supports Klotho expression and reduces the inflammatory burden that suppresses it
- Manage metabolic health aggressively, as insulin sensitivity and body composition both directly influence Klotho production.
- Prioritize sleep quality, since Klotho expression is sensitive to chronic sleep deprivation and circadian disruption.
Biomarkers worth asking your physician about include the following:
- Serum Cystatin C with a CKD-EPI Cystatin C-based eGFR
- Serum FGF23
- Serum phosphate
- Serum calcium
- 25-OH Vitamin D
- High-sensitivity CRP as a proxy for the inflammatory burden driving Klotho suppression
- Urine albumin-to-creatinine ratio (UACR) for early glomerular damage
- And my general recommendations for vital biomarkers if you haven’t already built a full panel yet
While direct serum Klotho testing exists, it remains an inexact science through most commercial labs today.
However, I optimistically expect that to change within the next year or two as demand catches up to the research.
A Note on Women and Klotho Biology
Estrogen directly supports Klotho gene expression, and findings from one study show post-menopausal declines in Klotho tracking alongside the cardiovascular risk increases women see after menopause.
My wife Monica and I have discussed this extensively, and here’s what you must know…
Optimizing estradiol levels in women during perimenopause and post-menopause preserves the hormonal environment that supports overall longevity and vitality.
If you’re a woman reading this, your Klotho trajectory is directly tied to whether you have a physician managing your hormone balance proactively or not.
Safety and Considerations
There are no FDA-approved Klotho-targeted drugs at the time of writing.
But let me correct something the rest of the Internet keeps getting wrong: An engineered and third-party-verified alpha-Klotho protein already exists, and you can find more information about it here.
It is currently available through BioLongevity Labs, manufactured to a US GMP standard with third-party certificate-of-analysis verification, and it is recommended to dose it at roughly 10mcg subcutaneously every other week.
Use code JAYC for 15% OFF!
A grey-market vial from a vendor with a Shopify store and no third-party testing, on the other hand, is a completely different animal and you should treat it with nothing less than extreme skepticism.
What I will NOT do is wait for a patentable drug and a decade of FDA-blessed human trials while the the animal data and the epidemiology are all sharply pointing in the same direction.
However, there is an important caveat I want to disclose…
More is not better when it comes to using Klotho.
For instance, the primate research showed a low dose producing cognitive benefits while the high dose produced none at all.
If you go down this road, make sure you’re tracking the relevant biomarkers (serum phosphate, serum calcium, kidney function markers, blood pressure, baseline soluble Klotho if your lab can run it, etc.).
And make sure to do so alongside an optimization-minded clinician who already knows what FGF23 is.
The Kidney Is the Longevity Gland Nobody Told You About
The kidney is a filtration organ, but it also happens to be a longevity gland that produces the single most important anti-aging protein we’ve identified to date.
The same protein known to regulate the phosphate-vitamin D-FGF23 axis that governs cardiovascular aging along with bone health and cognitive resilience simultaneously.
But tapping into optimal Klotho use requires you to break free from the chains of the conventional medical system.
After you understand how it works, you have to track the right biomarkers alongside the right practitioner.
Klotho represents the next frontier of serious health optimization, but only for the people who start taking ownership of their kidney health before disease rears its ugly head.
The information exists…. now it’s time to for you decide if you’re willing to seek it out.
Isn’t It Time You Became Fully Optimized To Live Leaner, Longer And Stronger?
Join my #1 online membership group, Fully Optimized Health to receive guidance from me and an elite group of more than 800 male and female biohackers (who all started out just like you).
And don’t forget to check out our other premium educational content dedicated to helping you fully optimize your health:
Quantum Peptides – the A-to-Z system for anyone (newbies & pros alike) desiring to master peptide use for the first time and forever.
Quantum Testosterone – the A-to-Z system for Men & Women to learn to optimize their hormones for explosive energy, lean muscle, and timeless vitality.
The Ultimate GLP-1 Video Masterclass – how to PROPERLY utilize the world’s most powerful weight loss drugs for enhanced fat loss and overall longevity.
The Modern Woman’s Peptide Course – a must-have resource for any woman seeking to become more feminine, sexier, leaner, and healthier through the use of peptides.
Life Enhanced – Unlock the secrets to TOTAL Mind-Body-Spirit Optimization as Hunter Williams and I teach you how to live at the tip of the spear.
30 Days 2 Shredz – Reprogram Your Mind and Body for Maximum Fat Loss in Minimum Time with our Optimized Fasting Protocol
Monica Campbell’s 3 Day PMF Video Training Program – Ignite unbreakable strength, sculpt lean muscle, and conquer workouts fearlessly with my wife Monica’s 3 Day Video training course.
Positive Muscle Failure Video Training Program – Learn how to lift weights correctly for maximum muscle in minimum time while building the physique of your dreams.
See you on the inside!
